Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Is This Cancer Drug Really a Vaccine?
Motley Fool
Saturday, March 9, 2013 - 12:31pm
tags:
Dendreon, cancer vaccines, vaccines, Provenge
Johnson & Johnson Could Tap The Huge Diabetes Market With New Drug Approval
Seeking Alpha
Saturday, March 9, 2013 - 12:29pm
tags:
type 2 diabetes, JNJ, diabetes, canagliflozin
The Investor's Best Health Care Stock in the Dow
Motley Fool
Saturday, March 9, 2013 - 12:28pm
tags:
Pfizer
Pacira keeps rising; analyst sees more gains ahead
Yahoo/AP
Saturday, March 9, 2013 - 12:27pm
tags:
Pacira
Pfizer Halts Production Of Hepatitis C Drug
Wall Street Cheat Street
Saturday, March 9, 2013 - 12:26pm
tags:
Pfizer, hepatitis C, Filibuvir
What You Were Selling Last Week: GlaxoSmithKline
Motley Fool
Saturday, March 9, 2013 - 12:24pm
tags:
GSK
6 Reasons To Buy Dendreon Right Now
Seeking Alpha
Saturday, March 9, 2013 - 12:23pm
tags:
Dendreon
The Obesity Drug War Continues
Motley Fool
Saturday, March 9, 2013 - 11:56am
tags:
obesity, weight loss, Arena Pharmaceuticals, Belviq, Vivus, Qsymia
First Manhattan seeks seats on Vivus board as diet drug founders
Reuters
Saturday, March 9, 2013 - 11:52am
tags:
Vivus, obesity, weight loss, Qsymia
Spec Stock: Cramer Profiles an Orphan Drug Maker (video)
CNBC
Saturday, March 9, 2013 - 11:50am
tags:
Cinryze, hereditary angiodema, ViroPharma, orphan drugs
Elan will start $1B Dutch auction for shares
Yahoo/AP
Saturday, March 9, 2013 - 11:45am
tags:
Elan
Osiris Wows The Market With Stellar Earnings Report
Seeking Alpha
Saturday, March 9, 2013 - 11:44am
tags:
Osiris Therapeutics
Is Celgene Recession-Resistant?
Wall Street Cheat Street
Saturday, March 9, 2013 - 11:43am
tags:
Celgene
Arena Cuts Loss, Misses Estimates
Yahoo/Zacks
Saturday, March 9, 2013 - 11:42am
tags:
Arena Pharmaceuticals
Why Sequenom Shares Slumped
Motley Fool
Saturday, March 9, 2013 - 11:42am
tags:
Sequenom
Eisai fires back at G-BA rebuff of Fycompa
Fierce Pharma
Friday, March 8, 2013 - 11:18am
tags:
Eisai, Fycompa, epilepsy
Investors Seeing Huge Potential In RNA Drug Developers
Seeking Alpha
Friday, March 8, 2013 - 11:17am
tags:
Sarepta, RXi Pharmaceuticals, OPKO, Alnylam
Cadence Pharmaceuticals Beats on Both Top and Bottom Lines
Motley Fool
Friday, March 8, 2013 - 11:12am
tags:
Cadence Pharmaceuticals, earnings
Amgen And The Biosimilar Threat: Lessons From Affymax
Seeking Alpha
Friday, March 8, 2013 - 11:12am
tags:
biosimilars, Amgen, Affymax, AbbVie, Biogen Idec, Celgene, Fresenius, Merck, Gilead
Delcath Systems: Bullish On Melblez FDA Panel Vote And Subsequent Approval
Seeking Alpha
Friday, March 8, 2013 - 11:10am
tags:
Delcath, FDA, advisory panels, Melblez, ocular melanoma

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.